Cargando…
COVID-19 Follow-App. Mobile App-Based Monitoring of COVID-19 Patients after Hospital Discharge: A Single-Center, Open-Label, Randomized Clinical Trial
Introduction: In the midst of a pandemic, apps can be used to provide close follow-up, ensure that patients are monitored at home, avoid excessive pressure on medical facilities, prevent the movement of people (both patients and health professionals), and reduce the risk of infection. Objective: To...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777713/ https://www.ncbi.nlm.nih.gov/pubmed/35055339 http://dx.doi.org/10.3390/jpm12010024 |
_version_ | 1784637132943392768 |
---|---|
author | Marquez-Algaba, Ester Sanchez, Marc Baladas, Maria España, Claudia Dallo, Hermes Salvatore Requena, Manuel Torrella, Ariadna Planas, Bibiana Raventos, Berta Molina, Carlos Ribo, Marc Almirante, Benito Len, Oscar |
author_facet | Marquez-Algaba, Ester Sanchez, Marc Baladas, Maria España, Claudia Dallo, Hermes Salvatore Requena, Manuel Torrella, Ariadna Planas, Bibiana Raventos, Berta Molina, Carlos Ribo, Marc Almirante, Benito Len, Oscar |
author_sort | Marquez-Algaba, Ester |
collection | PubMed |
description | Introduction: In the midst of a pandemic, apps can be used to provide close follow-up, ensure that patients are monitored at home, avoid excessive pressure on medical facilities, prevent the movement of people (both patients and health professionals), and reduce the risk of infection. Objective: To adapt and validate the use of a smartphone application for outpatient follow-up of COVID-19 patients after hospital discharge. Methods: We conducted an open-label clinical trial at Hospital Universitari Vall d’Hebron in Barcelona, Spain. Patients were randomly assigned in a 1:1 ratio to be followed by the Farmalarm app or by their primary care center. The primary endpoint was the reduction in the need for in-person return visits. Results: From 31 March to 4 May 2020, 150 patients were enrolled in the study at hospital discharge: 74 patients were randomized to the experimental group, and 76 to the control group. All patients in the control group and all except for six in the experimental group completed the study. During hospitalization, before study inclusion, all but 4 (97.3%) had viral pneumonia, 91 (60.7%) required supplemental oxygen, and 16 (10.7%) required intensive care unit (ICU) admission. COVID-19–related return visits to the emergency department were significantly higher in the control group (7.9% vs. 0%; p = 0.028) in the per-protocol analysis. Telephone consultations with the emergency department were performed by 12 (15.8%) patients in the control group and 0 (0%) in the experimental group (p < 0.001). Satisfaction with outpatient monitoring was rated higher by the experimental group (5 vs. 4 points; p < 0.001). Conclusions: Following COVID-19 hospital discharge, home follow-up via a mobile app was effective in reducing in-person return visits without undermining patient satisfaction or perception of health, compared with standard follow-up. |
format | Online Article Text |
id | pubmed-8777713 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87777132022-01-22 COVID-19 Follow-App. Mobile App-Based Monitoring of COVID-19 Patients after Hospital Discharge: A Single-Center, Open-Label, Randomized Clinical Trial Marquez-Algaba, Ester Sanchez, Marc Baladas, Maria España, Claudia Dallo, Hermes Salvatore Requena, Manuel Torrella, Ariadna Planas, Bibiana Raventos, Berta Molina, Carlos Ribo, Marc Almirante, Benito Len, Oscar J Pers Med Article Introduction: In the midst of a pandemic, apps can be used to provide close follow-up, ensure that patients are monitored at home, avoid excessive pressure on medical facilities, prevent the movement of people (both patients and health professionals), and reduce the risk of infection. Objective: To adapt and validate the use of a smartphone application for outpatient follow-up of COVID-19 patients after hospital discharge. Methods: We conducted an open-label clinical trial at Hospital Universitari Vall d’Hebron in Barcelona, Spain. Patients were randomly assigned in a 1:1 ratio to be followed by the Farmalarm app or by their primary care center. The primary endpoint was the reduction in the need for in-person return visits. Results: From 31 March to 4 May 2020, 150 patients were enrolled in the study at hospital discharge: 74 patients were randomized to the experimental group, and 76 to the control group. All patients in the control group and all except for six in the experimental group completed the study. During hospitalization, before study inclusion, all but 4 (97.3%) had viral pneumonia, 91 (60.7%) required supplemental oxygen, and 16 (10.7%) required intensive care unit (ICU) admission. COVID-19–related return visits to the emergency department were significantly higher in the control group (7.9% vs. 0%; p = 0.028) in the per-protocol analysis. Telephone consultations with the emergency department were performed by 12 (15.8%) patients in the control group and 0 (0%) in the experimental group (p < 0.001). Satisfaction with outpatient monitoring was rated higher by the experimental group (5 vs. 4 points; p < 0.001). Conclusions: Following COVID-19 hospital discharge, home follow-up via a mobile app was effective in reducing in-person return visits without undermining patient satisfaction or perception of health, compared with standard follow-up. MDPI 2022-01-01 /pmc/articles/PMC8777713/ /pubmed/35055339 http://dx.doi.org/10.3390/jpm12010024 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Marquez-Algaba, Ester Sanchez, Marc Baladas, Maria España, Claudia Dallo, Hermes Salvatore Requena, Manuel Torrella, Ariadna Planas, Bibiana Raventos, Berta Molina, Carlos Ribo, Marc Almirante, Benito Len, Oscar COVID-19 Follow-App. Mobile App-Based Monitoring of COVID-19 Patients after Hospital Discharge: A Single-Center, Open-Label, Randomized Clinical Trial |
title | COVID-19 Follow-App. Mobile App-Based Monitoring of COVID-19 Patients after Hospital Discharge: A Single-Center, Open-Label, Randomized Clinical Trial |
title_full | COVID-19 Follow-App. Mobile App-Based Monitoring of COVID-19 Patients after Hospital Discharge: A Single-Center, Open-Label, Randomized Clinical Trial |
title_fullStr | COVID-19 Follow-App. Mobile App-Based Monitoring of COVID-19 Patients after Hospital Discharge: A Single-Center, Open-Label, Randomized Clinical Trial |
title_full_unstemmed | COVID-19 Follow-App. Mobile App-Based Monitoring of COVID-19 Patients after Hospital Discharge: A Single-Center, Open-Label, Randomized Clinical Trial |
title_short | COVID-19 Follow-App. Mobile App-Based Monitoring of COVID-19 Patients after Hospital Discharge: A Single-Center, Open-Label, Randomized Clinical Trial |
title_sort | covid-19 follow-app. mobile app-based monitoring of covid-19 patients after hospital discharge: a single-center, open-label, randomized clinical trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777713/ https://www.ncbi.nlm.nih.gov/pubmed/35055339 http://dx.doi.org/10.3390/jpm12010024 |
work_keys_str_mv | AT marquezalgabaester covid19followappmobileappbasedmonitoringofcovid19patientsafterhospitaldischargeasinglecenteropenlabelrandomizedclinicaltrial AT sanchezmarc covid19followappmobileappbasedmonitoringofcovid19patientsafterhospitaldischargeasinglecenteropenlabelrandomizedclinicaltrial AT baladasmaria covid19followappmobileappbasedmonitoringofcovid19patientsafterhospitaldischargeasinglecenteropenlabelrandomizedclinicaltrial AT espanaclaudia covid19followappmobileappbasedmonitoringofcovid19patientsafterhospitaldischargeasinglecenteropenlabelrandomizedclinicaltrial AT dallohermessalvatore covid19followappmobileappbasedmonitoringofcovid19patientsafterhospitaldischargeasinglecenteropenlabelrandomizedclinicaltrial AT requenamanuel covid19followappmobileappbasedmonitoringofcovid19patientsafterhospitaldischargeasinglecenteropenlabelrandomizedclinicaltrial AT torrellaariadna covid19followappmobileappbasedmonitoringofcovid19patientsafterhospitaldischargeasinglecenteropenlabelrandomizedclinicaltrial AT planasbibiana covid19followappmobileappbasedmonitoringofcovid19patientsafterhospitaldischargeasinglecenteropenlabelrandomizedclinicaltrial AT raventosberta covid19followappmobileappbasedmonitoringofcovid19patientsafterhospitaldischargeasinglecenteropenlabelrandomizedclinicaltrial AT molinacarlos covid19followappmobileappbasedmonitoringofcovid19patientsafterhospitaldischargeasinglecenteropenlabelrandomizedclinicaltrial AT ribomarc covid19followappmobileappbasedmonitoringofcovid19patientsafterhospitaldischargeasinglecenteropenlabelrandomizedclinicaltrial AT almirantebenito covid19followappmobileappbasedmonitoringofcovid19patientsafterhospitaldischargeasinglecenteropenlabelrandomizedclinicaltrial AT lenoscar covid19followappmobileappbasedmonitoringofcovid19patientsafterhospitaldischargeasinglecenteropenlabelrandomizedclinicaltrial |